RMD
ResMed Inc
NYSE: RMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$211.93
-2.40% today
Updated 2026-04-29
Market cap
$30.87B
P/E ratio
20.96
P/S ratio
5.72x
EPS (TTM)
$10.11
Dividend yield
1.04%
52W range
$212 – $292
Volume
1.0M
ResMed Inc (RMD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $99.03M | $91.11M | $137.84M | $238.88M | $188.21M | $283.19M | $383.16M | $402.82M | $391.27M | $383.18M | $547.93M | $414.05M | $505.03M | $459.05M | $802.25M | $736.72M | $351.15M | $693.30M | $1.40B | $1.75B |
| Capital expenditures | $102.75M | $77.56M | $75.78M | $114.22M | $61.64M | $75.00M | $61.11M | $71.78M | $81.16M | $71.94M | $67.83M | $71.48M | $71.46M | $77.34M | $105.94M | $116.83M | $156.04M | $134.00M | $114.86M | $89.86M |
| Depreciation | $41.62M | $48.14M | $59.48M | $53.96M | $61.56M | $10.15M | $85.86M | $78.28M | $73.45M | $73.06M | $86.85M | $112.16M | $119.96M | $150.79M | $181.37M | $191.52M | $193.84M | $197.56M | $216.21M | $235.81M |
| Stock-based comp | — | $59.70M | $1.89M | $25.52M | $29.73M | $30.81M | $30.59M | $38.16M | $43.46M | $47.85M | $46.41M | $45.92M | $48.41M | $52.07M | $57.56M | $63.93M | $65.26M | $71.14M | $80.18M | $91.66M |
| Free cash flow | $-3.72M | $13.55M | $62.06M | $124.66M | $126.57M | $208.19M | $322.05M | $331.04M | $310.11M | $311.24M | $480.10M | $342.58M | $433.57M | $381.71M | $696.32M | $619.89M | $195.11M | $559.30M | $1.29B | $1.66B |
| Investing cash flow | $-119.87M | $-105.42M | $-37.85M | $-109.30M | $-58.31M | $-76.51M | $-101.61M | $-78.00M | $-94.99M | $-143.07M | $-1.13B | $-81.89M | $-101.82M | $-1.08B | $-179.86M | $-158.46M | $-229.92M | $-1.16B | $-269.78M | $-200.04M |
| Financing cash flow | $97.77M | $38.10M | $-63.76M | $1.87M | $-61.13M | $-79.34M | $-177.10M | $-153.93M | $-297.32M | $-255.79M | $612.58M | $-262.87M | $-1.03B | $580.64M | $-317.29M | $-764.63M | $-128.36M | $422.87M | $-1.12B | $-606.25M |
| Dividends paid | — | — | — | — | — | $98.43M | $270.38M | $97.20M | $141.52M | $157.26M | $168.13M | $186.35M | $199.50M | $211.71M | $225.09M | $226.71M | $245.34M | $258.28M | $282.32M | $310.88M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $246.49M | $74.27M | $66.51M | $29.68M | $-188.48M | $14.19M | $90.50M | $-633.23M | $-41.57M | $316.03M | — | — | — | — | — |